The Whole Pharmacy Picture: What Comes Next for PharmPix

Key Takeaway: PharmPix’s new brand reflects a long-held belief: a pharmacy benefit should see more than a transaction. By bringing clinical insight, technology and a more connected view of the member together earlier, PharmPix aims to protect patients and plans before a prescription becomes a problem.

Q: Pharmacy benefits are entering a new era. Where do you see the industry heading?

MARTTY: For a long time, the industry’s loudest conversations centered on discounts and rebates. Today, transparency’s becoming a requirement. More rebate value is moving to the point of sale. Employers are being asked to understand not only what their pharmacy benefit costs, but what their PBM retains and what’s driving that spend.

Those are important changes. PharmPix is prepared for them. But once you have transparency, the question becomes: Now what? Transparency can show you what happened. It doesn’t tell you why it happened, whether the therapy was right for the member or whether the cost could have been avoided altogether.

A claim can be priced correctly and still be wrong for the person. A plan can receive a rebate and still pay for something that never should have been dispensed. So, the next step is using the information we have to make better decisions earlier.

Q: What does that next step look like for PharmPix?

MARTTY: It means connecting what happens in the physician’s office with what happens at the pharmacy counter.

Medical and pharmacy information often sit in separate places. A pharmacy shows what was dispensed, but not the diagnosis, lab result or broader health history that explains why it was prescribed. Medical data may indicate that a member is approaching a significant change in therapy, but the pharmacy benefit may not see it until the first claim arrives.

We’re working toward a more connected view: bringing diagnoses, labs, medication history and other clinical information together. That could mean identifying a medication conflict before a prescription is dispensed. Recognizing that a member may be approaching a high-cost therapy before the first pharmacy claim appears. Or identifying members using a high-cost reference biologic so the clinical team can evaluate whether a lower-cost biosimilar may be appropriate.

For us, that’s what comes next: using a more complete picture to protect members from avoidable harm and plans from avoidable cost.

Q: How does that direction connect to the evolution of the PharmPix brand?

IVELISSE: Pharmacy has become too consequential for an incomplete story. Specialty medications are reshaping health plan budgets. Employers are being asked to defend how their pharmacy benefits operate. Families feel the consequences when they fill a prescription: in real dollars, real uncertainty and, sometimes, real fear.

PharmPix was built to catch what others might miss. Now, we’re building toward an even more connected view of the member and the population.

But when we looked at our brand, we realized it didn’t fully express who we were, why our work mattered or where we’re going. The distance between the company we had become and the story we were telling had grown too wide.

Q: So what did “evolving the brand” actually look like from the inside?

IVELISSE: We began by listening to our people and the clients we serve every single day.

Again and again, the same story emerged. We found it in the pharmacists who contact prescribers, the case managers who stay on the line, the clinicians who look for patterns and the engineers who have built and continually strengthened our technology in-house.

They described a company that doesn’t stop at whether a claim can be processed. Our technology identifies risks in real time. Our pharmacists bring clinical judgment. And our teams follow through until the issue is resolved.

We connect the pieces that others often leave separate.

Q: Where did The Whole Pharmacy Picture—and the pixel—come from?

IVELISSE: It came directly out of those conversations. What our people, and our clients, described in different words was the same thing: no single piece of pharmacy makes sense on its own.

We gave that a name: The Whole Pharmacy Picture. And the pixel isn’t new. It’s been in our name since 2009, and it has always meant what it means now.

A single pixel reveals almost nothing. Connected to thousands of others, it brings an entire picture into view. Pharmacy is no different: a claim, a clinical signal, a cost, a conversation at the counter, a person trying to stay well. Viewed separately, each offers only a fragment. Together, they reveal where risk may be hiding, what’s driving cost and what needs to happen next.

This isn’t a departure from who PharmPix has been. It’s a clearer expression of the belief that has shaped the company from the beginning and continues to guide where we are going.

Q: What’s the standard you’re asking to be held to going forward?

MARTTY: PharmPix was founded by pharmacists who believed patients deserved more protection than the final seconds at a pharmacy counter could provide. As we bring more information together and move intelligence earlier in the process, our work is to make sure that by the time a prescription reaches that counter, the hard part has already been done.

For our future, The Whole Pharmacy Picture is more than our tagline. It’s a standard we’re choosing to make public, and asking to be held to.

Zoom out far enough, and a pharmacy benefit becomes a number in a budget. Move closer, and it becomes a claim. Closer still, and it’s a person standing at a pharmacy counter, trusting that someone, somewhere, has seen more than a transaction.

That belief is where PharmPix began. What comes next is the ability to see more, sooner, and act while there’s still time to change the outcome.

That’s The Whole Pharmacy Picture.

‍